These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 9560197)

  • 1. Protein-bound acrolein: potential markers for oxidative stress.
    Uchida K; Kanematsu M; Sakai K; Matsuda T; Hattori N; Mizuno Y; Suzuki D; Miyata T; Noguchi N; Niki E; Osawa T
    Proc Natl Acad Sci U S A; 1998 Apr; 95(9):4882-7. PubMed ID: 9560197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins.
    Uchida K; Kanematsu M; Morimitsu Y; Osawa T; Noguchi N; Niki E
    J Biol Chem; 1998 Jun; 273(26):16058-66. PubMed ID: 9632657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of acrolein-specific adducts generated during lipid peroxidation-modification of proteins in vitro: identification of N(τ)-(3-propanal)histidine as the major adduct.
    Maeshima T; Honda K; Chikazawa M; Shibata T; Kawai Y; Akagawa M; Uchida K
    Chem Res Toxicol; 2012 Jul; 25(7):1384-92. PubMed ID: 22716039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody against protein-bound glutathione: use of glutathione conjugate of acrolein-modified proteins as an immunogen.
    Furuhata A; Honda K; Shibata T; Chikazawa M; Kawai Y; Shibata N; Uchida K
    Chem Res Toxicol; 2012 Jul; 25(7):1393-401. PubMed ID: 22716076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of acrolein as a lipid peroxidation product.
    Uchida K
    Trends Cardiovasc Med; 1999 Jul; 9(5):109-13. PubMed ID: 10639724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covalent binding of oxidized cholesteryl esters to protein: implications for oxidative modification of low density lipoprotein and atherosclerosis.
    Kawai Y; Saito A; Shibata N; Kobayashi M; Yamada S; Osawa T; Uchida K
    J Biol Chem; 2003 Jun; 278(23):21040-9. PubMed ID: 12663661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous formation of protein adducts with carcinogenic aldehydes: implications for oxidative stress.
    Ichihashi K; Osawa T; Toyokuni S; Uchida K
    J Biol Chem; 2001 Jun; 276(26):23903-13. PubMed ID: 11283024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein-bound 4-hydroxy-2-hexenal as a marker of oxidized n-3 polyunsaturated fatty acids.
    Yamada S; Funada T; Shibata N; Kobayashi M; Kawai Y; Tatsuda E; Furuhata A; Uchida K
    J Lipid Res; 2004 Apr; 45(4):626-34. PubMed ID: 14729859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiolation of protein-bound carcinogenic aldehyde. An electrophilic acrolein-lysine adduct that covalently binds to thiols.
    Furuhata A; Nakamura M; Osawa T; Uchida K
    J Biol Chem; 2002 Aug; 277(31):27919-26. PubMed ID: 12032148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of oxidized phospholipid-protein adducts using anti-15-hydroperoxyeicosatetraenoic acid-modified protein antibody: contribution of esterified fatty acid-protein adduct to oxidative modification of LDL.
    Kato Y; Osawa T
    Arch Biochem Biophys; 1998 Mar; 351(1):106-14. PubMed ID: 9500842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of acrolein-derived 2'-deoxyadenosine adduct in an iron-induced carcinogenesis model.
    Kawai Y; Furuhata A; Toyokuni S; Aratani Y; Uchida K
    J Biol Chem; 2003 Dec; 278(50):50346-54. PubMed ID: 14522963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of lipofuscin-like fluorophore in oxidized human low-density lipoprotein. 4-hydroxy-2-nonenal as a potential source of fluorescent chromophore.
    Itakura K; Oya-Ito T; Osawa T; Yamada S; Toyokuni S; Shibata N; Kobayashi M; Uchida K
    FEBS Lett; 2000 May; 473(2):249-53. PubMed ID: 10812084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease.
    Calingasan NY; Uchida K; Gibson GE
    J Neurochem; 1999 Feb; 72(2):751-6. PubMed ID: 9930749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunochemical detection of a lipofuscin-like fluorophore derived from malondialdehyde and lysine.
    Yamada S; Kumazawa S; Ishii T; Nakayama T; Itakura K; Shibata N; Kobayashi M; Sakai K; Osawa T; Uchida K
    J Lipid Res; 2001 Aug; 42(8):1187-96. PubMed ID: 11483619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of the presence of lipid peroxide-modified proteins in human atherosclerotic lesions using a novel lipid peroxide-modified anti-peptide antibody.
    Kim JG; Taylor WR; Parthasarathy S
    Atherosclerosis; 1999 Apr; 143(2):335-40. PubMed ID: 10217362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis.
    Uchida K; Toyokuni S; Nishikawa K; Kawakishi S; Oda H; Hiai H; Stadtman ER
    Biochemistry; 1994 Oct; 33(41):12487-94. PubMed ID: 7918471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a specific polyclonal antibody against 13-hydroperoxyoctadecadienoic acid-modified protein: formation of lipid hydroperoxide-modified apoB-100 in oxidized LDL.
    Kato Y; Makino Y; Osawa T
    J Lipid Res; 1997 Jul; 38(7):1334-46. PubMed ID: 9254060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maillard reaction-like lysine modification by a lipid peroxidation product: immunochemical detection of protein-bound 2-hydroxyheptanal in vivo.
    Itakura K; Furuhata A; Shibata N; Kobayashi M; Uchida K
    Biochem Biophys Res Commun; 2003 Aug; 308(3):452-7. PubMed ID: 12914770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of lipid-lysine amide-type adduct as a marker of PUFA oxidation and its applications.
    Kato Y; Osawa T
    Arch Biochem Biophys; 2010 Sep; 501(2):182-7. PubMed ID: 20558129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions.
    Fu MX; Requena JR; Jenkins AJ; Lyons TJ; Baynes JW; Thorpe SR
    J Biol Chem; 1996 Apr; 271(17):9982-6. PubMed ID: 8626637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.